Brainstorm Cell Therapeutics In

Q2 2019 13F Holders

Symbol
BCLI
CUSIP
10501E201
Type
Equity
Class
COM NEW
Num filings
45
Total reported value, excl. options
$8.24 M
Manager Report Date Value ($000) Shares Option Type